Related Experiment Videos
[Effect of combination chemotherapy with adriamycin in elderly non-Hodgkin's lymphoma patients]
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|February 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Tirabrutinib hydrochloride for B-cell lymphomas.
Drugs of today (Barcelona, Spain : 1998)·2021
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Complement-coagulation crosstalk in immunothrombosis].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Enhancing intravesical bladder cancer therapy: from mucoadhesive to targeted drug delivery strategies.
Frontiers in medicine·2026
Bio-based nanophotothermal systems as smart drug delivery platforms for multimodal synergistic cancer therapy-a review.
Frontiers in medical technology·2026